Related Experiment Videos
PTEN function: how normal cells control it and tumour cells lose it.
Nick R Leslie1, C Peter Downes
1Division of Cell Signalling, School of Life Sciences, University of Dundee, Dundee DD1 5EH, UK. n.r.leslie@dundee.ac.uk
The Biochemical Journal
|June 15, 2004
Summary
The PTEN tumour suppressor regulates cell growth and motility. Loss of PTEN function, through mutation or reduced expression, is common in cancer and other diseases, with mechanisms of expression loss still under investigation.
Area of Science:
- Molecular Biology
- Oncology
- Biochemistry
Background:
- PTEN (phosphatase and tensin homologue deleted on chromosome 10) is a crucial tumour suppressor and PI (phosphoinositide) 3-phosphatase.
- It inhibits cellular proliferation, survival, and growth by regulating PI 3-kinase signalling and also suppresses motility.
- PTEN deregulation is implicated in human cancers and other diseases.
Purpose of the Study:
- To review recent advancements in understanding PTEN regulation.
- To explore mechanisms of PTEN activity loss in tumours.
- To highlight the importance of PTEN in disease.
Main Methods:
- Literature review of recent developments in PTEN research.
- Discussion of regulatory mechanisms including oxidation and phosphorylation.
- Analysis of PTEN expression and mutation in cancer.
Main Results:
- PTEN activity is regulated by controlling gene expression and enzyme activity via oxidation and phosphorylation.
- Tumour PTEN disruption affects both catalytic function and regulatory aspects.
- Loss of PTEN expression is more frequent than mutation in many cancers.
Conclusions:
- Understanding PTEN regulation is key to understanding its role in cancer.
- Mechanisms of PTEN expression loss in tumours without mutation require further research.
- PTEN's dual role in catalysis and regulation is critical for its tumour-suppressive function.